Skyhawk Therapeutics has announced that its investigational drug, SKY-0515, has met the eligibility criteria for provisional registration by Australia’s Therapeutic Goods Administration (TGA). This...
BREAKING: The Australian government has just announced the approval of a new COVID-19 vaccine, developed by Pfizer-BioNTech, which is now available for public distribution....